Qilu Antibiotics

Qilu Pharmaceutical is a leading Chinese pharmaceutical enterprise that operates a vertically integrated business model covering the entire value chain from R&D to manufacturing and sales. The Qilu Antibiotics segment, primarily based in Inner Mongolia, represents one of the world's largest manufacturing hubs for antibiotic active pharmaceutical ingredients (APIs) and intermediates. Beyond its legacy in anti-infectives, the company has built a robust portfolio in oncology, cardiovascular, and neurology, with a significant focus on developing biosimilars and innovative biologics. Qilu maintains a global presence with multiple R&D centers in China and the United States, exporting products to over 70 countries. The company is recognized for its large-scale fermentation capabilities and its successful transition from a generics-focused manufacturer to an innovation-driven biopharmaceutical player.